Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	succinyl-CoA:3-oxo-acid CoA-transferase activity	OXCT1 OXCT2	1.11e-05	2	67	2	GO:0008260
GeneOntologyMolecularFunction	structural constituent of postsynaptic intermediate filament cytoskeleton	NEFH NEFL	3.32e-05	3	67	2	GO:0099184
GeneOntologyMolecularFunction	CoA-transferase activity	OXCT1 OXCT2	1.10e-04	5	67	2	GO:0008410
GeneOntologyMolecularFunction	calmodulin binding	SLC8A1 SMTNL1 MYH11 CAMKK1 AKAP12 RYR3	1.21e-04	230	67	6	GO:0005516
GeneOntologyMolecularFunction	calcium ion binding	CACNA1B S100B SLC8A1 DST OTOF NINL NBPF26 MACF1 CDH10 RYR3	1.86e-04	749	67	10	GO:0005509
GeneOntologyBiologicalProcess	postsynaptic intermediate filament cytoskeleton organization	NEFH NEFL	2.93e-05	3	65	2	GO:0099185
GeneOntologyBiologicalProcess	neurofilament bundle assembly	NEFH NEFL	2.93e-05	3	65	2	GO:0033693
GeneOntologyBiologicalProcess	ketone body catabolic process	OXCT1 OXCT2	2.93e-05	3	65	2	GO:0046952
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	SLC8A1 CHD7 RYR3	2.15e-04	37	65	3	GO:0014808
GeneOntologyBiologicalProcess	release of sequestered calcium ion into cytosol by endoplasmic reticulum	SLC8A1 CHD7 RYR3	2.52e-04	39	65	3	GO:1903514
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	NEFH NEFL DST MACF1	2.70e-04	99	65	4	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament bundle assembly	NEFH NEFL	2.70e-04	8	65	2	GO:0045110
GeneOntologyBiologicalProcess	response to sodium arsenite	NEFH NEFL	2.70e-04	8	65	2	GO:1903935
GeneOntologyBiologicalProcess	intermediate filament-based process	NEFH NEFL DST MACF1	2.81e-04	100	65	4	GO:0045103
GeneOntologyBiologicalProcess	sarcoplasmic reticulum calcium ion transport	SLC8A1 CHD7 RYR3	3.61e-04	44	65	3	GO:0070296
GeneOntologyBiologicalProcess	ketone body metabolic process	OXCT1 OXCT2	5.28e-04	11	65	2	GO:1902224
GeneOntologyBiologicalProcess	neurofilament cytoskeleton organization	NEFH NEFL	5.28e-04	11	65	2	GO:0060052
GeneOntologyBiologicalProcess	succinyl-CoA metabolic process	OXCT2 DLST	5.28e-04	11	65	2	GO:0006104
GeneOntologyBiologicalProcess	cellular response to caffeine	SLC8A1 RYR3	5.28e-04	11	65	2	GO:0071313
GeneOntologyCellularComponent	postsynaptic intermediate filament cytoskeleton	NEFH NEFL	6.79e-05	4	71	2	GO:0099160
Domain	NBPF_dom	NBPF15 NBPF9 NBPF11 NBPF14	4.90e-08	11	67	4	IPR010630
Domain	NBPF	NBPF15 NBPF9 NBPF11 NBPF14	4.90e-08	11	67	4	PS51316
Domain	DUF1220	NBPF15 NBPF9 NBPF11 NBPF14	4.90e-08	11	67	4	PF06758
Domain	DUF1220	NBPF15 NBPF9 NBPF11	3.65e-06	9	67	3	SM01148
Domain	3-oxoacid_CoA-transf_A	OXCT1 OXCT2	1.27e-05	2	67	2	IPR012792
Domain	3-oxoacid_CoA-transf_B	OXCT1 OXCT2	1.27e-05	2	67	2	IPR012791
Domain	CoA_trans	OXCT1 OXCT2	1.27e-05	2	67	2	SM00882
Domain	CoA_transf_AS	OXCT1 OXCT2	1.27e-05	2	67	2	IPR004164
Domain	CoA_trans_fam_I	OXCT1 OXCT2	1.27e-05	2	67	2	IPR004165
Domain	CoA_transf_BS	OXCT1 OXCT2	1.27e-05	2	67	2	IPR004163
Domain	CoA_trans	OXCT1 OXCT2	1.27e-05	2	67	2	PF01144
Domain	3-oxoacid_CoA-transferase	OXCT1 OXCT2	1.27e-05	2	67	2	IPR014388
Domain	COA_TRANSF_2	OXCT1 OXCT2	1.27e-05	2	67	2	PS01274
Domain	COA_TRANSF_1	OXCT1 OXCT2	1.27e-05	2	67	2	PS01273
Domain	zf-CCCH	MKRN4P RBM27 ZC3H8 TRMT1	2.84e-05	49	67	4	PF00642
Domain	SANT	BDP1 EP400 CHD7 MIDEAS	3.08e-05	50	67	4	SM00717
Domain	SANT/Myb	BDP1 EP400 CHD7 MIDEAS	3.60e-05	52	67	4	IPR001005
Domain	Znf_CCCH	MKRN4P RBM27 ZC3H8 TRMT1	5.55e-05	58	67	4	IPR000571
Domain	EF_HAND_2	CACNA1B S100B DST NINL MACF1 RYR3	1.78e-04	231	67	6	PS50222
Domain	EF_hand_dom	CACNA1B S100B DST NINL MACF1 RYR3	1.83e-04	232	67	6	IPR002048
Domain	-	DST MACF1	1.88e-04	6	67	2	3.90.1290.10
Domain	GAR	DST MACF1	1.88e-04	6	67	2	PS51460
Domain	-	DST MACF1	1.88e-04	6	67	2	3.30.920.20
Domain	GAS_dom	DST MACF1	1.88e-04	6	67	2	IPR003108
Domain	GAS2	DST MACF1	1.88e-04	6	67	2	PF02187
Domain	GAS2	DST MACF1	1.88e-04	6	67	2	SM00243
Domain	EF-hand_1	S100B DST NINL MACF1 RYR3	2.15e-04	152	67	5	PF00036
Domain	Plectin_repeat	DST MACF1	2.63e-04	7	67	2	IPR001101
Domain	Plectin	DST MACF1	2.63e-04	7	67	2	PF00681
Domain	PLEC	DST MACF1	2.63e-04	7	67	2	SM00250
Domain	MYB_LIKE	BDP1 EP400 MIDEAS	3.40e-04	38	67	3	PS50090
Domain	-	RBM27 ZC3H8 TRMT1	3.96e-04	40	67	3	4.10.1000.10
Domain	EF-hand-dom_pair	CACNA1B S100B DST NINL MACF1 RYR3	5.68e-04	287	67	6	IPR011992
Domain	ZnF_C3H1	MKRN4P ZC3H8 TRMT1	6.80e-04	48	67	3	SM00356
Domain	ZF_C3H1	RBM27 ZC3H8 TRMT1	1.18e-03	58	67	3	PS50103
Domain	-	S100B DST NINL MACF1 RYR3	2.45e-03	261	67	5	1.10.238.10
Domain	EFh	S100B DST NINL MACF1	2.50e-03	158	67	4	SM00054
Domain	Actinin_actin-bd_CS	DST MACF1	3.06e-03	23	67	2	IPR001589
Domain	Spectrin	DST MACF1	3.06e-03	23	67	2	PF00435
Domain	ACTININ_2	DST MACF1	3.06e-03	23	67	2	PS00020
Domain	ACTININ_1	DST MACF1	3.06e-03	23	67	2	PS00019
Domain	EF-hand_7	DST NINL MACF1	3.53e-03	85	67	3	PF13499
Domain	EF_Hand_1_Ca_BS	S100B DST NINL MACF1	3.61e-03	175	67	4	IPR018247
Domain	Spectrin_repeat	DST MACF1	4.84e-03	29	67	2	IPR002017
Domain	SNF2_N	EP400 CHD7	5.87e-03	32	67	2	IPR000330
Domain	Spectrin/alpha-actinin	DST MACF1	5.87e-03	32	67	2	IPR018159
Domain	SNF2_N	EP400 CHD7	5.87e-03	32	67	2	PF00176
Domain	SPEC	DST MACF1	5.87e-03	32	67	2	SM00150
Domain	EF_HAND_1	S100B DST NINL MACF1	6.20e-03	204	67	4	PS00018
Domain	Helicase_C	DDX46 EP400 CHD7	6.71e-03	107	67	3	PF00271
Domain	HELICc	DDX46 EP400 CHD7	6.71e-03	107	67	3	SM00490
Domain	Helicase_C	DDX46 EP400 CHD7	6.89e-03	108	67	3	IPR001650
Domain	DNA/RNA_helicase_DEAH_CS	EP400 CHD7	6.99e-03	35	67	2	IPR002464
Domain	HELICASE_CTER	DDX46 EP400 CHD7	7.07e-03	109	67	3	PS51194
Domain	HELICASE_ATP_BIND_1	DDX46 EP400 CHD7	7.07e-03	109	67	3	PS51192
Domain	DEXDc	DDX46 EP400 CHD7	7.07e-03	109	67	3	SM00487
Pathway	REACTOME_UTILIZATION_OF_KETONE_BODIES	OXCT1 OXCT2	7.07e-05	4	49	2	MM15459
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF8 NBPF19 NBPF15 NBPF9 NBPF10 NBPF11 NBPF14	1.52e-14	21	73	7	16079250
Pubmed	Evolutionary history and genome organization of DUF1220 protein domains.	NBPF8 NBPF15 NBPF9 NBPF14	3.71e-09	10	73	4	22973535
Pubmed	The intermediate filament protein peripherin is the specific interaction partner of mouse BPAG1-n (dystonin) in neurons.	NEFH NEFL DST	8.84e-08	5	73	3	9971739
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	NBPF8 NEFH NBPF15 DST NBPF9 MDC1 NBPF10 COX10 NBPF11 NBPF14	1.21e-07	513	73	10	25798074
Pubmed	Spatial proteomics reveal that the protein phosphatase PTP1B interacts with and may modify tyrosine phosphorylation of the rhomboid protease RHBDL4.	DST TLN1 SEC23IP FNDC3A CHD7 GOLGB1 AKAP12	1.62e-07	191	73	7	31177093
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DDX46 DST EP400 RBM27 TLN1 PDZK1 MDC1 ZFP91 NBPF26 MACF1 CHD7 CKAP2 GOLGB1 NOL8 IWS1	4.16e-07	1497	73	15	31527615
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	DDX46 DST EP400 RBM27 PUF60 TLN1 SEC23IP MACF1 CKAP2 GOLGB1 AKAP12 NOL8	5.36e-07	934	73	12	33916271
Pubmed	Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.	DDX46 DST EP400 PUF60 NELFA TLN1 MDC1 DLST GOLGB1	1.16e-06	506	73	9	30890647
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	FMNL3 CEP104 DDX46 DST EP400 RBM27 MDC1 NINL FNDC3A	1.67e-06	529	73	9	14621295
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	HMGN5 DDX46 DST EP400 RBM27 ZC3H8 MDC1 NKTR CHD7 CKAP2 MIDEAS NOL8 IWS1	2.67e-06	1294	73	13	30804502
Pubmed	Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.	NEFH NEFL	4.35e-06	2	73	2	33609080
Pubmed	Differential expression of succinyl CoA transferase (SCOT) genes in somatic and germline cells of the mouse testis.	OXCT1 OXCT2	4.35e-06	2	73	2	12534938
Pubmed	Acf7 (MACF) is an actin and microtubule linker protein whose expression predominates in neural, muscle, and lung development.	DST MACF1	4.35e-06	2	73	2	11002341
Pubmed	An autosomal recessive nonsyndromic form of sensorineural hearing loss maps to 3p-DFNB6.	OTOF TMIE	4.35e-06	2	73	2	8593615
Pubmed	Attenuated neurodegenerative disease phenotype in tau transgenic mouse lacking neurofilaments.	NEFH NEFL	4.35e-06	2	73	2	11487626
Pubmed	Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease.	NEFH NEFL	4.35e-06	2	73	2	28500227
Pubmed	CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls.	NEFH NEFL	4.35e-06	2	73	2	17290105
Pubmed	Neurofilament levels in patients with neurological diseases: A comparison of neurofilament light and heavy chain levels.	NEFH NEFL	4.35e-06	2	73	2	31199010
Pubmed	Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.	NEFH NEFL	4.35e-06	2	73	2	27732645
Pubmed	Focal increases of axoplasmic Ca2+, aggregation of sodium-calcium exchanger, N-type Ca2+ channel, and actin define the sites of spheroids in axons undergoing oxidative stress.	CACNA1B SLC8A1	4.35e-06	2	73	2	22933787
Pubmed	Comparative study of CSF neurofilaments in HTLV-1-associated myelopathy/tropical spastic paraparesis and other neurological disorders.	NEFH NEFL	4.35e-06	2	73	2	19678766
Pubmed	Heterodimeric associations between neuronal intermediate filament proteins.	NEFH NEFL	4.35e-06	2	73	2	9388258
Pubmed	Integrators of the cytoskeleton that stabilize microtubules.	NEFL DST	4.35e-06	2	73	2	10428034
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	AVEN MYH11 DDX46 EP400 RBM27 PUF60 TLN1 ZFP91 DLST NKTR CHD7 CLPX MIDEAS	5.00e-06	1371	73	13	36244648
Pubmed	A critical role for the chromatin remodeller CHD7 in anterior mesoderm during cardiovascular development.	NEFL CHD7 RYR3	5.91e-06	17	73	3	26102480
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	MYH11 DDX46 OXCT1 DST RBM27 DLST CLPX	6.31e-06	331	73	7	29199018
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	DST OTOF MDC1 MACF1 DLST GOLGB1	1.02e-05	234	73	6	36243803
Pubmed	Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits.	NEFH NEFL	1.30e-05	3	73	2	10461886
Pubmed	Mitotic regulator Nlp interacts with XPA/ERCC1 complexes and regulates nucleotide excision repair (NER) in response to UV radiation.	NINL XPA	1.30e-05	3	73	2	26805762
Pubmed	Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.	NEFH NEFL	1.30e-05	3	73	2	11050249
Pubmed	Peripherin-mediated death of motor neurons rescued by overexpression of neurofilament NF-H proteins.	NEFH NEFL	1.30e-05	3	73	2	12641746
Pubmed	Sequence and structure of the mouse gene coding for the largest neurofilament subunit.	NEFH NEFL	1.30e-05	3	73	2	3220257
Pubmed	Neurofilament homeostasis and motoneurone degeneration.	NEFH NEFL	1.30e-05	3	73	2	11135306
Pubmed	Mutations in neurofilament genes are not a significant primary cause of non-SOD1-mediated amyotrophic lateral sclerosis.	NEFH NEFL	1.30e-05	3	73	2	16084104
Pubmed	Overexpression of the human NFM subunit in transgenic mice modifies the level of endogenous NFL and the phosphorylation state of NFH subunits.	NEFH NEFL	1.30e-05	3	73	2	7790359
Pubmed	PKN associates and phosphorylates the head-rod domain of neurofilament protein.	NEFH NEFL	1.30e-05	3	73	2	8621664
Pubmed	Chd7 deficiency delays leukemogenesis in mice induced by Cbfb-MYH11.	MYH11 CHD7	1.30e-05	3	73	2	29018080
Pubmed	Expression of the mouse Macf2 gene during inner ear development.	DST MACF1	1.30e-05	3	73	2	12399109
Pubmed	Neurofilament-deficient axons and perikaryal aggregates in viable transgenic mice expressing a neurofilament-beta-galactosidase fusion protein.	NEFH NEFL	1.30e-05	3	73	2	8110465
Pubmed	Neurofilaments and motor neuron disease.	NEFH NEFL	1.30e-05	3	73	2	17708953
Pubmed	Transgenic mice in the study of ALS: the role of neurofilaments.	NEFH NEFL	1.30e-05	3	73	2	9804382
Pubmed	Cloning and characterization of a human orthologue of testis-specific succinyl CoA: 3-oxo acid CoA transferase (Scot-t) cDNA.	OXCT1 OXCT2	1.30e-05	3	73	2	11756565
Pubmed	Neurofilaments bind tubulin and modulate its polymerization.	NEFH NEFL	1.30e-05	3	73	2	19726663
Pubmed	Negative regulatory regions are present upstream in the three mouse neurofilament genes.	NEFH NEFL	1.30e-05	3	73	2	1315909
Pubmed	Neurofilament Protein as a Potential Biomarker of Axonal Degeneration in Experimental Autoimmune Encephalomyelitis.	NEFH NEFL	1.30e-05	3	73	2	32189712
Pubmed	Methylation and expression of neurofilament genes in tissues and in cell lines of the mouse.	NEFH NEFL	1.30e-05	3	73	2	8510499
Pubmed	Axonal atrophy in aging is associated with a decline in neurofilament gene expression.	NEFH NEFL	1.30e-05	3	73	2	7563228
Pubmed	TMIE Defines Pore and Gating Properties of the Mechanotransduction Channel of Mammalian Cochlear Hair Cells.	TMC1 TMIE	1.30e-05	3	73	2	32343945
Pubmed	Alternative Splicing of Three Genes Encoding Mechanotransduction-Complex Proteins in Auditory Hair Cells.	TMC1 TMIE	1.30e-05	3	73	2	33509951
Pubmed	NF-M is an essential target for the myelin-directed "outside-in" signaling cascade that mediates radial axonal growth.	NEFH NEFL	1.30e-05	3	73	2	14662745
Pubmed	Cloning and developmental expression of the murine neurofilament gene family.	NEFH NEFL	1.30e-05	3	73	2	3103856
Pubmed	Developmental expression of BPAG1-n: insights into the spastic ataxia and gross neurologic degeneration in dystonia musculorum mice.	NEFH DST	1.30e-05	3	73	2	9242412
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NEFL DDX46 DST EP400 RBM27 PUF60 ZC3H8 MACF1 DLST CHD7 IWS1	1.53e-05	1082	73	11	38697112
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	DDX46 EP400 RBM27 PUF60 TLN1 MDC1 SEC23IP MIDEAS	2.00e-05	549	73	8	38280479
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	EP400 RBM27 NELFA MDC1 CHD7 MIDEAS	2.19e-05	268	73	6	33640491
Pubmed	Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.	DST RBM27 PUF60 TLN1 SEC23IP FNDC3A CHML AKAP12	2.55e-05	568	73	8	37774976
Pubmed	How the projection domains of NF-L and alpha-internexin determine the conformations of NF-M and NF-H in neurofilaments.	NEFH NEFL	2.60e-05	4	73	2	20213320
Pubmed	Sensory transduction is required for normal development and maturation of cochlear inner hair cell synapses.	TMC1 TMIE	2.60e-05	4	73	2	34734805
Pubmed	LOXHD1 is indispensable for maintaining TMC1 auditory mechanosensitive channels at the site of force transmission.	TMC1 TMIE	2.60e-05	4	73	2	39256406
Pubmed	Laminin gamma1 is critical for Schwann cell differentiation, axon myelination, and regeneration in the peripheral nerve.	NEFH S100B	2.60e-05	4	73	2	14638863
Pubmed	Neurofilament transport in vivo minimally requires hetero-oligomer formation.	NEFH NEFL	2.60e-05	4	73	2	14561875
Pubmed	Cx43 gap junction gene expression and gap junctional communication in mouse neural crest cells.	NEFH NEFL	2.60e-05	4	73	2	9144923
Pubmed	Cloning and characterization of mouse ACF7, a novel member of the dystonin subfamily of actin binding proteins.	DST MACF1	2.60e-05	4	73	2	8954775
Pubmed	Mechanotransduction-Dependent Control of Stereocilia Dimensions and Row Identity in Inner Hair Cells.	TMC1 TMIE	2.60e-05	4	73	2	31902726
Pubmed	Regionalized neurofilament accumulation and motoneuron degeneration are linked phenotypes in wobbler neuromuscular disease.	NEFH NEFL	2.60e-05	4	73	2	11493023
Pubmed	The toppler mouse: a novel mutant exhibiting loss of Purkinje cells.	NEFH S100B	2.60e-05	4	73	2	15248193
Pubmed	Development of LBP110 expression by neural crest-derived enteric precursors: migration and differentiation potential in ls/ls mutant mice.	NEFH NEFL	2.60e-05	4	73	2	9624616
Pubmed	Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo.	NEFH NEFL	2.60e-05	4	73	2	25869803
Pubmed	Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS.	NEFH NEFL	2.60e-05	4	73	2	17005864
Pubmed	The conductance and organization of the TMC1-containing mechanotransducer channel complex in auditory hair cells.	TMC1 TMIE	2.60e-05	4	73	2	36191207
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	DDX46 EP400 RBM27 MDC1 CHD7 NOL8	2.97e-05	283	73	6	30585729
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	NBPF8 NBPF9 NBPF10 NBPF11 NBPF14	3.02e-05	170	73	5	23314748
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	NBPF19 EP400 NBPF9 TLN1 MDC1 CHD7 NBPF14	3.39e-05	430	73	7	35044719
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	AVEN DST EP400 CCDC146 SEC23IP RELL1 GOLGB1 AKAP12 NOL8	3.59e-05	777	73	9	35844135
Pubmed	Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?	NEFH NEFL	4.33e-05	5	73	2	11090858
Pubmed	Basal enrichment within neuroepithelia suggests novel function(s) for Celsr1 protein.	NEFH NEFL	4.33e-05	5	73	2	20353824
Pubmed	Neurodegeneration Markers in the Cerebrospinal Fluid of 100 Patients with Schizophrenia Spectrum Disorder.	NEFH NEFL	4.33e-05	5	73	2	36200879
Pubmed	The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury.	NEFH S100B	4.33e-05	5	73	2	21976236
Pubmed	Non-syndromic hearing impairment in India: high allelic heterogeneity among mutations in TMPRSS3, TMC1, USHIC, CDH23 and TMIE.	TMC1 TMIE	4.33e-05	5	73	2	24416283
Pubmed	Myosin Va binding to neurofilaments is essential for correct myosin Va distribution and transport and neurofilament density.	NEFH NEFL	4.33e-05	5	73	2	12403814
Pubmed	TMIE is an essential component of the mechanotransduction machinery of cochlear hair cells.	TMC1 TMIE	4.33e-05	5	73	2	25467981
Pubmed	Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions.	NEFH NEFL	4.33e-05	5	73	2	11343650
Pubmed	NCAM in the organ of Corti of the developing mouse.	NEFH NEFL	4.33e-05	5	73	2	2292721
Pubmed	Early upregulation of medium neurofilament gene expression in developing spinal cord of the wobbler mouse mutant.	NEFH NEFL	4.33e-05	5	73	2	8793115
Pubmed	Different expression of synemin isoforms in glia and neurons during nervous system development.	NEFH NEFL	4.33e-05	5	73	2	16817202
Pubmed	Distribution of neuronal intermediate filament proteins in the developing mouse olfactory system.	NEFH NEFL	4.33e-05	5	73	2	9819140
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	DDX46 EP400 RBM27 PUF60 NELFA CENPH MDC1 ZFP91 XPA IWS1	5.00e-05	1014	73	10	32416067
Pubmed	The DNA sequence and biological annotation of human chromosome 1.	CEP104 GPR161 NBPF15 PDZK1 NBPF10 MACF1 GBP3 NBPF11 CHML DNAI3	5.74e-05	1031	73	10	16710414
Pubmed	Involvement of Wnt-1 in the formation of the mes/metencephalic boundary.	NEFH NEFL	6.48e-05	6	73	2	8555108
Pubmed	Neuromuscular synapses mediate motor axon branching and motoneuron survival during the embryonic period of programmed cell death.	NEFH NEFL	6.48e-05	6	73	2	12710958
Pubmed	A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons.	NEFH NEFL	6.48e-05	6	73	2	15208636
Pubmed	Slit1 and Slit2 cooperate to prevent premature midline crossing of retinal axons in the mouse visual system.	NEFH NEFL	6.48e-05	6	73	2	11804570
Pubmed	The murine catecholamine methyltransferase mTOMT is essential for mechanotransduction by cochlear hair cells.	TMC1 TMIE	6.48e-05	6	73	2	28504928
Pubmed	Acetylation of ELF5 suppresses breast cancer progression by promoting its degradation and targeting CCND1.	DDX46 RBM27 PUF60 TLN1 ZFP91 TRMT1 CLPX IWS1	6.80e-05	653	73	8	33742100
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	NEFL DDX46 DST PUF60 TLN1 MDC1 MACF1 CHD7	6.80e-05	653	73	8	22586326
Pubmed	Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development.	CACNA1B SLC8A1 RYR3	7.10e-05	38	73	3	30786075
Pubmed	Expanding roles for alpha 4 integrin and its ligands in development.	NEFH NEFL	9.06e-05	7	73	2	7526952
Pubmed	Transcription factor AP-2 essential for cranial closure and craniofacial development.	NEFH NEFL	9.06e-05	7	73	2	8622765
Pubmed	Correct expression and localization of collagen XIII are crucial for the normal formation and function of the neuromuscular system.	NEFH S100B	9.06e-05	7	73	2	30667565
Pubmed	Substituting mouse transcription factor Pou4f2 with a sea urchin orthologue restores retinal ganglion cell development.	NEFH NEFL	9.06e-05	7	73	2	26962139
Interaction	HERC2 interactions	CEP104 DDX46 DST PUF60 MDC1 SEC23IP MACF1 FNDC3A XPA CKAP2	1.30e-05	503	73	10	int:HERC2
Interaction	DUXB interactions	MDC1 CHD7 MIDEAS	3.58e-05	18	73	3	int:DUXB
Interaction	CLEC3A interactions	RCAN1 RBM27 ZFP91 CLPX	3.76e-05	52	73	4	int:CLEC3A
Interaction	NAA40 interactions	HMGN5 DDX46 DST EP400 RBM27 PUF60 TLN1 SEC23IP MACF1 CKAP2 GOLGB1 AKAP12 NOL8	4.39e-05	978	73	13	int:NAA40
Interaction	NEK4 interactions	NBPF8 NEFH NBPF15 DST NBPF9 MDC1 NBPF10 COX10 NBPF11 NBPF14	4.52e-05	582	73	10	int:NEK4
Cytoband	1q21.1	NBPF8 NBPF9 NBPF10 NBPF11 NBPF14	5.33e-08	62	73	5	1q21.1
Cytoband	Ensembl 112 genes in cytogenetic band chr1q21	NBPF19 NBPF15 NBPF9 PDZK1 NBPF10 NBPF11 NBPF14	3.84e-06	404	73	7	chr1q21
Cytoband	Ensembl 112 genes in cytogenetic band chr1p11	NBPF8 NBPF26	5.14e-04	21	73	2	chr1p11
GeneFamily	Neuroblastoma breakpoint family	NBPF8 NBPF19 NBPF15 NBPF9 NBPF10 NBPF26 NBPF11 NBPF14	7.59e-16	23	49	8	662
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	BDP1 EP400 CHD7 MIDEAS	1.26e-05	53	49	4	532
GeneFamily	EF-hand domain containing	CACNA1B S100B DST NINL MACF1 RYR3	2.67e-05	219	49	6	863
GeneFamily	Intermediate filaments Type IV	NEFH NEFL	1.07e-04	6	49	2	611
GeneFamily	EF-hand domain containing\|Plakins	DST MACF1	1.99e-04	8	49	2	939
GeneFamily	Actins\|Deafness associated genes	TMC1 OTOF TMIE	3.55e-03	113	49	3	1152
GeneFamily	Zinc fingers CCCH-type	RBM27 ZC3H8	4.04e-03	35	49	2	73
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	CEP104 TLN1 MACF1 FNDC3A CHD7 IWS1	1.12e-05	180	73	6	M8239
Coexpression	GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN	BDP1 AVEN MYH11 NELFA NBPF10 RELL1	1.93e-05	198	73	6	M3352
Coexpression	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN	CEP104 OXCT1 PUF60 PDZK1 NINL RASSF9	1.93e-05	198	73	6	M6841
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	BDP1 DDX46 PLXNC1 NINL CHD7 NOL8 IWS1	5.39e-06	204	71	7	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 DDX46 OXCT1 PLXNC1 CHD7 NOL8 IWS1	1.25e-05	232	71	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	BDP1 HMGN5 DDX46 DST CENPH MDC1 CHD7 NOL8 IWS1	2.56e-05	469	71	9	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5	BDP1 HMGN5 DDX46 OXCT1 MACF1 FNDC3A CHD7 CKAP2 GOLGB1 IWS1	4.39e-05	629	71	10	Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	BDP1 DDX46 RBM27 PLXNC1 CENPH NINL CHD7 NOL8 IWS1	6.81e-05	532	71	9	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000	BDP1 CACNA1B HMGN5 MDC1 NINL MACF1 XPA CHD7 RELL1 GOLGB1 NOL8 IWS1	8.94e-05	979	71	12	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	PLXNC1 MDC1 ZFP91 NINL MACF1 FNDC3A CHD7 CKAP2 GOLGB1	1.59e-04	595	71	9	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	BDP1 HMGN5 NEFH DDX46 NKTR GOLGB1 NOL8	3.54e-08	197	73	7	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBPF19 PRR16 GPR161 NBPF10 NBPF14 RYR3	5.85e-07	184	73	6	658f2e522055e88c92bc482a845c40f8f5f1a8e3
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	S100B MYH11 DST TLN1 MACF1 GOLGB1	7.05e-07	190	73	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	COPD-Myeloid-ncMonocyte\|COPD / Disease state, Lineage and Cell class	NBPF19 SLC8A1 PLXNC1 NBPF26 FAM117B NBPF14	7.73e-07	193	73	6	936ca95995599356b794fba32bfd82d8de339365
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DDX46 DST RCAN1 RBM27 GOLGB1 AKAP12	7.96e-07	194	73	6	8985095f291c1b54e45f4edece49aa26e8c8b732
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NEFH S100B TDO2 AKAP12 RYR3	2.78e-06	134	73	5	cb676d5bbc468bd3ce1b6712d41c986ee9221ac5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMNL3 NBPF19 PRR16 GPR161 DNAH14	9.64e-06	173	73	5	8335b77f730ed43fc348a005566e73a103c6774b
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBPF19 PRR16 NBPF14 DNAH14 RYR3	9.92e-06	174	73	5	ae363ce736fc8af439f3ad594d7bc2e344db80d4
ToppCell	COVID-19-Myeloid-MoAM4\|COVID-19 / Condition, Lineage and Cell class	NEFL S100B SLC8A1 DST DNAH14	1.08e-05	177	73	5	ca5d0c3d5c700bbe4c2da068eb02be6229afb9a0
ToppCell	ILEUM-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	SLC8A1 DST NKTR CHML GOLGB1	1.40e-05	187	73	5	0099def970fbc828756fbf853eca2ce77b8cd342
ToppCell	COPD-Myeloid-cMonocyte\|COPD / Disease state, Lineage and Cell class	NBPF19 PLXNC1 NBPF10 NBPF26 NBPF14	1.48e-05	189	73	5	d29f3a0bd23e6eb46389e6eb7ef21851c7b57545
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRR16 SLC8A1 MYH11 DST AKAP12	1.52e-05	190	73	5	2e88e366d377d74deb53a4ea870973ce5c6532e8
ToppCell	COPD-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	NBPF19 PLXNC1 NBPF26 FAM117B NBPF14	1.52e-05	190	73	5	ed978cd5d9da87b49878a330e362762c487f849f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRR16 SLC8A1 MYH11 DST AKAP12	1.52e-05	190	73	5	0028f886c789ba238c031eae5d96acaed4af8c25
ToppCell	Control-B_intermediate-10\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CEP104 PRR16 WWC2 PLXNC1 TLN1	1.59e-05	192	73	5	224bd958369ba8fa0d7be2126f7dc61c9f6ac19d
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	NBPF19 SLC8A1 PLXNC1 NBPF26 NBPF14	1.72e-05	195	73	5	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 DST MACF1 NKTR GOLGB1	1.72e-05	195	73	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC8A1 DST MACF1 NKTR GOLGB1	1.72e-05	195	73	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	NBPF19 SLC8A1 PLXNC1 NBPF26 NBPF14	1.72e-05	195	73	5	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DST MACF1 TDO2 DNAI3 AKAP12	1.80e-05	197	73	5	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NBPF19 S100B SLC8A1 PLXNC1 OXCT2	1.80e-05	197	73	5	61bda9b5102fdbce902bb976d1aa62f2c799d2fb
ToppCell	15-Distal-Mesenchymal-Mesenchyme_RSPO2+\|Distal / Age, Tissue, Lineage and Cell class	PRR16 DST MACF1 TDO2 AKAP12	1.85e-05	198	73	5	e87d1fe2befbd32b0c723ab43b9de95495ea3ee3
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	DST MACF1 TDO2 CKAP2 AKAP12	1.89e-05	199	73	5	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	(09)_Interm._secr.>cil.-(2)_GFP_FOXI1\|(09)_Interm._secr.>cil. / shred by cell type by condition	CEP104 DDX46 CCDC146 GOLGB1 IWS1	1.89e-05	199	73	5	fc680f85ebd3bab4c72876a19a461b0afb5f51ce
ToppCell	18-Distal-Mesenchymal\|Distal / Age, Tissue, Lineage and Cell class	MYH11 DST MACF1 TDO2 AKAP12	1.89e-05	199	73	5	d65150d2e24c40aa82712e7f034f6772102bd293
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DST MACF1 TDO2 CDH10 AKAP12	1.94e-05	200	73	5	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	DST MACF1 TDO2 DNAI3 AKAP12	1.94e-05	200	73	5	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GPR161 S100B AKAP12 RYR3	5.67e-05	127	73	4	fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	PRR16 S100B NBPF10 COX10	6.59e-05	132	73	4	a1fda8c5287168c4f159203ed27cadfb4ce1b131
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Slco2a1\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	NEFH S100B AKAP12 RYR3	6.78e-05	133	73	4	9d7a08170d38ae9b2ff10a0fa505aeb3aae2824d
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	DST MACF1 NKTR GOLGB1	7.19e-05	135	73	4	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_systemic\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PRR16 SLC8A1 MYH11 OXCT2	8.51e-05	141	73	4	dcc56aef1b31bfe0de84cb0b5c77d242681cf19c
ToppCell	Control-B_naive-1\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	NBPF15 NBPF10 MACF1 NBPF11	1.23e-04	155	73	4	0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HMGN5 NEFL CENPH DNAH14	1.26e-04	156	73	4	27590a4d2b419644966f0037c67c761fc275e0aa
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC8A1 DST OTOF CDH10	1.29e-04	157	73	4	e9d0300361b06aec3c216f8af15f09e14b12a4da
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SLC8A1 DST OTOF CDH10	1.32e-04	158	73	4	e9657d8960d499832f9f9b45b5a6f4388551b7e1
ToppCell	10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-LMPP\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	EP400 RBM27 NBPF26 FAM117B	1.39e-04	160	73	4	60fa1c717410aad7e8647703cb416cd7617cac29
ToppCell	Control-B_intermediate-10\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PRR16 WWC2 PLXNC1 TLN1	1.45e-04	162	73	4	aa80452b972bb8ad3670ffaba4ce26fadb33b185
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FMNL3 NBPF19 GPR161 DNAH14	1.71e-04	169	73	4	319cba07263bf41fcbcbfecd117f91b729394241
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEFL S100B SLC8A1 NINL	1.75e-04	170	73	4	a121e10099faaeb60251eec162f38caf7c4238c2
ToppCell	3'-Broncho-tracheal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMNL3 NEFH NBPF26 RYR3	1.79e-04	171	73	4	5885e69e997cc2f6a27afebfe57001ca0ac062a6
ToppCell	Control-B_naive-1\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	NBPF15 NBPF10 MACF1 NBPF11	1.79e-04	171	73	4	d18855b24aadea38fd1e4592f945cf15b85e05f1
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PRR16 MYH11 DST MACF1	1.95e-04	175	73	4	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEFL S100B SLC8A1 NINL	1.95e-04	175	73	4	f7cd2ef79d91d64976fcdb5f1e7343b24ba27456
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NBPF19 PRR16 NBPF14 DNAH14	2.00e-04	176	73	4	40993c41c1017b53039a337174fc56632b278609
ToppCell	NS-critical-d_0-4-Myeloid-Mast_cell\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CAMKK1 CENPH NBPF11 AKAP12	2.13e-04	179	73	4	6153e7a0eeae83e7d88f1a20093bf2113e8d66b1
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NBPF19 NBPF9 NBPF10 NBPF26	2.17e-04	180	73	4	b234668bf181522807470e396792e1b54890b719
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SLC8A1 DST PLXNC1 TRMT1	2.17e-04	180	73	4	2bc3fd2e4c249bf236340c5f0483747faa5c04ec
ToppCell	COVID-19_Convalescent\|World / Disease condition and Cell class	NBPF19 NBPF15 NBPF26 NBPF14	2.22e-04	181	73	4	a62115a8da486fc61225901c72b1ec70bcaf4c36
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH11 DST MACF1 AKAP12	2.22e-04	181	73	4	beb2771820956be8b190c0088ae3c4efdb53c897
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	S100B CENPH CHD7 CKAP2	2.22e-04	181	73	4	f2ebeb4941510c4b6e50f2379c574d1778d6ced1
ToppCell	COVID-19_Mild-CD4+_T_activated\|COVID-19_Mild / Disease condition and Cell class	NBPF15 DST NBPF10 NBPF11	2.27e-04	182	73	4	877b6e611626628e709568747512f2827ebb2795
ToppCell	CTRL-Myeloid-cDC\|CTRL / Disease state, Lineage and Cell class	S100B OXCT1 PLXNC1 DNAI3	2.32e-04	183	73	4	20c4d16de7e090df3556a4458f783383a26871b6
ToppCell	Mild/Remission-B_intermediate-10\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	PLXNC1 TLN1 NBPF10 MACF1	2.32e-04	183	73	4	278064c9f0582463b83bf156d34e77f60187613b
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDX46 GBP3 FNDC3A RELL1	2.36e-04	184	73	4	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	COPD-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	NBPF19 PLXNC1 NBPF26 NBPF14	2.36e-04	184	73	4	ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	S100B NBPF10 NBPF26 NBPF14	2.46e-04	186	73	4	41e03be964044dae690d566bd078dab3d8045eba
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NBPF8 SLC8A1 TMC1 TLN1	2.46e-04	186	73	4	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	S100B NBPF10 NBPF26 NBPF14	2.51e-04	187	73	4	dd1d91f101b837bba513f77defa6e6902b2c0570
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	S100B NBPF10 NBPF26 NBPF14	2.51e-04	187	73	4	ae90c263f80c36a410150d499e268d198944a3d9
ToppCell	Primary_Motor_Cortex_(M1)\|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NEFH NEFL S100B TDO2	2.51e-04	187	73	4	892a4d439a0aa90f254dd17e1edce1fdc3619510
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	S100B NBPF10 NBPF26 NBPF14	2.51e-04	187	73	4	5d3d68519c8e19f10c29f9d81712125be78ca15a
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	S100B NBPF10 NBPF26 NBPF14	2.51e-04	187	73	4	5c73010fe4c85fb5cc1273f5504821229ca0cc4b
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	SLC8A1 MYH11 MACF1 RYR3	2.57e-04	188	73	4	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	S100B CENPH CHD7 CKAP2	2.57e-04	188	73	4	33afe31b1093d317dc38c324197c6e91bf6c39d3
ToppCell	COPD-Myeloid-cMonocyte\|Myeloid / Disease state, Lineage and Cell class	NBPF19 PLXNC1 NBPF26 NBPF14	2.62e-04	189	73	4	6294691231c7d38707323cf31578a107d3b2c622
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	TMC1 FNDC3A NKTR GOLGB1	2.62e-04	189	73	4	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	COPD-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	NBPF19 NBPF26 FAM117B NBPF14	2.67e-04	190	73	4	aece860b5609ad5a8fc920d685f0d0ec71bf9018
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	DST MACF1 TDO2 RASSF9	2.67e-04	190	73	4	71e112dfb8c3190fe0286b45a046ea789eb6a8db
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FMNL3 RCAN1 GBP3 RELL1	2.72e-04	191	73	4	a7b18bcf27c38ad2353c239ecb309c80f3ef3359
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH11 OXCT1 CENPH CKAP2	2.83e-04	193	73	4	a332dfdcc48c405020014e644aa4d14fda98cc86
ToppCell	NS-critical-d_0-4-Lymphoid-NK\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HMGN5 AVEN OXCT1 DLST	2.83e-04	193	73	4	1b29525c5936d1b779253b8c20f059fa091c6127
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH11 MACF1 AKAP12 RYR3	2.83e-04	193	73	4	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	S100B DST PUF60 CHD7	2.83e-04	193	73	4	cdc44bf6f5436eb8a2d4720fe011dcb85ccecf87
ToppCell	PCW_07-8.5\|World / Celltypes from embryonic and fetal-stage human lung	OXCT1 CHD7 CKAP2 DNAH14	2.89e-04	194	73	4	5759c83308df017f1faae248e9b85388e25254f0
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-NK-NK-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NBPF19 EP400 MACF1 NKTR	2.89e-04	194	73	4	3211d89440a6f4a9b3d4cfb755890816944242ec
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRR16 MYH11 DST AKAP12	2.95e-04	195	73	4	d8ebb94f30d4a655d6b29dd6a3076be2403d2356
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TMC1 RELL1 AKAP12 RYR3	2.95e-04	195	73	4	fde8e7b38b3631109b95ef111c5f6e3f9878cfbd
ToppCell	Control-Neu_4\|Control / 5 Neutrophil clusters in COVID-19 patients	CEP104 BDP1 TRMT1 CKAP2	3.01e-04	196	73	4	b8b7b54ca17a08fa775507bb22b1c7248ada8f40
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DST MACF1 TDO2 RASSF9	3.01e-04	196	73	4	6730743cf088c419ccc2d28765769fc09d3ba6a7
ToppCell	367C-Fibroblasts-Fibroblast-C_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	DST MACF1 TDO2 RASSF9	3.01e-04	196	73	4	21dab89f3699037138a9c7a0e4dc98739a9fad9c
ToppCell	15-Distal-Mesenchymal\|Distal / Age, Tissue, Lineage and Cell class	MYH11 DST TDO2 AKAP12	3.01e-04	196	73	4	b8d95b5f4780e73d16dcc528e70a5496f0314373
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRR16 DST MACF1 TDO2	3.06e-04	197	73	4	31a1852911bda38543916585fda34255fd62a134
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	S100B DST CHD7 CKAP2	3.06e-04	197	73	4	cd7e34318b4ae72b7b312fda8cc0e041c2ac4ab5
ToppCell	Tracheal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_2\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FMNL3 S100B SLC8A1 PLXNC1	3.06e-04	197	73	4	febafd8f0f5bb9a09f496f240e6b6b5e9275669b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	WWC2 TMC1 CHD7 GOLGB1	3.06e-04	197	73	4	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Mild\|World / Condition, Lineage, Cell class and cell subclass	BDP1 DST NBPF14 GOLGB1	3.06e-04	197	73	4	476b0d0389f9fcd4614f6bb1f494281f467f6730
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	S100B DST RCAN1 AKAP12	3.06e-04	197	73	4	b2f4d7c301c0b24003374923b31d6d058e40b213
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PRR16 DST MACF1 TDO2	3.06e-04	197	73	4	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRR16 SLC8A1 MYH11 AKAP12	3.06e-04	197	73	4	ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	PRR16 DST MACF1 TDO2	3.06e-04	197	73	4	11a4c417f035e554431a8f03be13b5eefa3530c0
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	MACF1 TDO2 DNAI3 RYR3	3.12e-04	198	73	4	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMNL3 S100B SLC8A1 PLXNC1	3.12e-04	198	73	4	6a4161680b46b2c12353a693c403b5a4bb3da03f
ToppCell	18-Distal\|18 / Age, Tissue, Lineage and Cell class	MYH11 DST MACF1 TDO2	3.12e-04	198	73	4	d635398c6529c514e77c0dc9299e9cf00330c9e7
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	S100B DST CHD7 CKAP2	3.12e-04	198	73	4	a11ac83dbd69d1c068971266d7c7343d114a6294
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BDP1 MACF1 NKTR GOLGB1	3.18e-04	199	73	4	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	3'-GW_trimst-1-SmallIntestine-Neuronal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NEFL S100B DST CHD7	3.18e-04	199	73	4	86739a6f5e0fa7448389b97b3c4de41f2a7d7ebd
ToppCell	(00)_Basal-(2)_GFP_FOXI1\|(00)_Basal / shred by cell type by condition	RBM27 GOLGB1 AKAP12 IWS1	3.18e-04	199	73	4	19674e1eaeb51e4196d847cb62aa437c852951d3
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	DST MACF1 DNAI3 CDH10	3.18e-04	199	73	4	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	18-Distal-Mesenchymal-Mesenchyme_RSPO2+\|Distal / Age, Tissue, Lineage and Cell class	DST MACF1 TDO2 AKAP12	3.18e-04	199	73	4	95403988caef322314f4ed15415ad1a9a987adc1
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 MACF1 NKTR GOLGB1	4.13e-05	49	43	4	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	DST MACF1 NKTR GOLGB1	4.47e-05	50	43	4	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BDP1 DST MACF1 GOLGB1	4.47e-05	50	43	4	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Neighborhood of CCNF	DDX46 NELFA SEC23IP CLPX	2.55e-04	78	43	4	MORF_CCNF
Drug	Pesticides	NBPF8 NBPF15 NBPF9 NBPF10 NBPF11 NBPF14 AKAP12	4.37e-07	150	71	7	ctd:D010575
Drug	AC1L9896	SLC8A1 OXCT1 OXCT2	4.71e-06	11	71	3	CID000439892
Drug	AC1L3UHX	OXCT1 OXCT2	9.59e-06	2	71	2	CID000095516
Drug	AC1NQZW7	OXCT1 OXCT2	9.59e-06	2	71	2	CID005282334
Drug	CPD-627	OXCT1 OXCT2	9.59e-06	2	71	2	CID000439367
Drug	AC1LCVNZ	OXCT1 OXCT2	9.59e-06	2	71	2	CID000656887
Drug	naphthyl-2-methyl-succinate	OXCT1 OXCT2	9.59e-06	2	71	2	CID000656886
Drug	p-azidobenzoyl-CoA	OXCT1 OXCT2	2.87e-05	3	71	2	CID000194163
Drug	AC1L3O3D	NEFH NEFL OXCT2	3.19e-05	20	71	3	CID000092422
Drug	AC1L2LUF	OXCT1 OXCT2	5.73e-05	4	71	2	CID000074406
Drug	BAPPs	NEFH NEFL	5.73e-05	4	71	2	CID000134312
Drug	3-methyl-2,5-hexanedione	NEFH NEFL	5.73e-05	4	71	2	CID000107281
Drug	C4:1n-2	OXCT1 DST OXCT2	9.00e-05	28	71	3	CID000019499
Drug	2-isopropylpentanoic acid	NEFH NEFL	9.53e-05	5	71	2	CID000147513
Drug	3HB-4HB	OXCT1 OXCT2	9.53e-05	5	71	2	CID003081116
Drug	ammoniacal silver nitrate solution	NEFH NEFL	9.53e-05	5	71	2	CID000062774
Drug	AC1NS1NJ	OXCT1 OXCT2	9.53e-05	5	71	2	CID005327101
Drug	monoacetoacetin	OXCT1 OXCT2	9.53e-05	5	71	2	CID000125624
Drug	AC1L9IK6	NEFH NEFL MYH11	1.35e-04	32	71	3	CID000445780
Drug	oxalate	TMC1 OXCT1 PDZK1 OXCT2 RYR3	1.36e-04	158	71	5	CID000000971
Drug	diphenyl ditelluride	NEFH NEFL	1.43e-04	6	71	2	CID000100657
Drug	BPAS	DST TDO2	1.43e-04	6	71	2	CID000010718
Drug	AC1NQZWS	OXCT1 OXCT2	1.43e-04	6	71	2	CID005282341
Drug	1,3-diacetylbenzene	NEFH NEFL	1.43e-04	6	71	2	CID000023229
Drug	2-bromobutyrate	OXCT1 OXCT2	1.43e-04	6	71	2	CID000006655
Drug	AC1MRLG6	OXCT1 OXCT2	1.43e-04	6	71	2	CID003519889
Drug	diazomethane	CACNA1B OXCT1 DLST	1.62e-04	34	71	3	CID000009550
Disease	neuromyelitis optica (is_marker_for)	NEFH NEFL S100B	3.38e-07	7	64	3	DOID:8869 (is_marker_for)
Disease	Creutzfeldt-Jakob disease (is_marker_for)	NEFH NEFL S100B	1.16e-06	10	64	3	DOID:11949 (is_marker_for)
Disease	relapsing-remitting multiple sclerosis (is_marker_for)	NEFH NEFL S100B	4.35e-06	15	64	3	DOID:2378 (is_marker_for)
Disease	hearing impairment	TMC1 OTOF TMIE CHD7	6.24e-05	98	64	4	C1384666
Disease	multiple sclerosis (is_marker_for)	CACNA1B NEFH NEFL	1.67e-04	49	64	3	DOID:2377 (is_marker_for)
Disease	Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive	TMC1 OTOF TMIE	1.88e-04	51	64	3	cv:CN043650
Disease	congenital hypothyroidism (implicated_via_orthology)	NEFH NEFL	4.14e-04	14	64	2	DOID:0050328 (implicated_via_orthology)
Disease	Nonsyndromic genetic hearing loss	TMC1 OTOF TMIE	6.11e-04	76	64	3	cv:C5680182
Disease	hypothyroidism (biomarker_via_orthology)	NEFH NEFL OTOF	7.10e-04	80	64	3	DOID:1459 (biomarker_via_orthology)
Disease	Nonsyndromic Deafness	BDP1 TMC1 TMIE	7.36e-04	81	64	3	C3711374
Disease	Down Syndrome, Partial Trisomy 21	S100B RCAN1	7.73e-04	19	64	2	C0432416
Disease	Trisomy 21, Meiotic Nondisjunction	S100B RCAN1	7.73e-04	19	64	2	C0432417
Disease	Trisomy 21, Mitotic Nondisjunction	S100B RCAN1	7.73e-04	19	64	2	C0751081
Disease	Down Syndrome	S100B RCAN1	7.73e-04	19	64	2	C0013080
Disease	sciatic neuropathy (biomarker_via_orthology)	NEFH NEFL AKAP12	1.32e-03	99	64	3	DOID:11446 (biomarker_via_orthology)
Disease	brain ischemia (biomarker_via_orthology)	S100B SLC8A1 AKAP12	1.43e-03	102	64	3	DOID:2316 (biomarker_via_orthology)
Disease	preterm premature rupture of the membranes, spontaneous preterm birth	FMNL3 FNDC3A	1.69e-03	28	64	2	EFO_0006917, MONDO_0012511
Disease	hair colour measurement	GPR161 RBM27 NINL RASSF9 DNAI3 AKAP12	2.15e-03	615	64	6	EFO_0007822

Protein segments in the cluster

Peptide	Gene	Start	Entry
EEKSEVINDEVKVVT	EP400	436	Q96L91
EEICVTEEKVAELKQ	BDP1	1296	A6H8Y1
NSDIVCVEVDKEVVE	CLPX	581	O76031
TEVFDEKIEVHQEEV	AKAP12	401	Q02952
VIEDSIDVGKETKEE	COX10	126	Q12887
EKEIEEESVTESTKQ	DNAI3	166	Q8IWG1
AVEKETTEKEATEKE	CACNA1B	991	Q00975
TTEKEATEKEAEIVE	CACNA1B	996	Q00975
VKKQKESGEEVEIEE	CHD7	811	Q9P2D1
SKEEVKEVSIEDTGV	CKAP2	526	Q8WWK9
TKEESEEEQTAVETK	MKRN4P	231	Q13434
SLEVTDVEESVEKEK	CHML	166	P26374
VVVHVCESDQEKEEE	RCAN1	211	P53805
EIEKEVKSVCIDINE	RASSF9	286	O75901
LVQEKEEIKEEVFQE	RBM27	91	Q9P2N5
LEEEKGETQVKEAED	IWS1	496	Q96ST2
ENVEDASHEEVVEKV	PDZK1	186	Q5T2W1
KVEIETSEEIQEKQV	MDC1	891	Q14676
EVSQKTVIIKEEEED	MDC1	1831	Q14676
EVVEKPAKEETVVEN	NELFA	281	Q9H3P2
EETEKVAAVKQLEES	DST	3761	Q03001
EEHCSVVEVTEEEVK	CAMKK1	421	Q8N5S9
VESEVDTELEVKIQK	PLXNC1	851	O60486
KEAVAAEVKNEEEDQ	HMGN5	116	P82970
TDQILTEKEKEIEVE	GBP3	476	Q9H0R5
EVNEKKTAEEEELAE	NOL8	896	Q76FK4
EEKVVEEEKQEHVEK	MACF1	1416	Q9UPN3
TVAEDEVVCEIETDK	DLST	96	P36957
VVEKSEKETVIVEEQ	NEFH	446	P12036
TIAMTEEVEDEQVKE	CCDC82	491	Q8N4S0
EIQAEVQEKESDAVK	CEP104	711	O60308
KIEDLENEIEEVKVA	CENPH	81	Q9H3R5
LKSKEDGEVVQEEEV	AVEN	311	Q9NQS1
KDTTIVKISIEDVDE	CDH10	366	Q9Y6N8
TQVDTEIEEKDEETK	FNDC3A	246	Q9Y2H6
QEIEIIIKETGEKEE	FAM117B	351	Q6P1L5
EDAETKNVALEKVEE	FMNL3	386	Q8IVF7
ETDDNIFEEIEKVVK	DNAH14	1546	Q0VDD8
EKSAQEEVEVDIKTS	MIDEAS	896	Q6PJG2
VTFEDEVEQIKEAAK	GPR161	431	Q8N6U8
SDVEQQVIVIEEEKK	DDX46	591	Q7L014
EAVVKVDVAEEEKEK	OTOF	1291	Q9HC10
VVDLSEQEEEKVELK	TRMT1	116	Q9NXH9
EKQGEEEDAEIIVKI	PUF60	501	Q9UHX1
IQAKEESEEKEEQVA	TDO2	241	P48775
EEEEIDDKQVTQESK	NKTR	1026	P30414
DDEDVQVEVAEKVQK	NBPF8	406	Q3BBV2
DDEDVQIEVAEKVQK	NBPF9	441	P0DPF3
DDEDVQVEVAEKVQK	NBPF10	441	Q6P3W6
DDEDVQVEVAEKVQK	NBPF11	441	Q86T75
DDEDVQVEVAEKVQK	NBPF14	101	Q5TI25
DEDVQVEVAEKVQKS	NBPF15	171	Q8N660
DEDVQVEVAEKVQKS	NBPF19	171	A0A087WUL8
DDEDVQVEVAEKVQK	NBPF26	101	B4DH59
DVAKELKEVVDQIDT	PRR16	46	Q569H4
EEIKEQEVVDKVMET	S100B	46	P04271
EEEEKQVVEAEKVVE	SEC23IP	911	Q9Y6Y8
KAAETTVVEVEEIVD	OXCT1	236	P55809
QKEIVEVVEKLSDSE	NINL	501	Q9Y2I6
KAADVTAVEVEEIVE	OXCT2	236	Q9BYC2
VQIKVEEKEDETEES	TMC1	6	Q8TDI8
SAIVDEKENVIKEVE	CCDC146	281	Q8IYE0
KEEKGDEVVVELVEN	MYH11	51	P35749
EASDEIVAEKEAEVK	WWC2	901	Q6AWC2
EEAKAESQKAVVEDE	SMTNL1	196	A8MU46
AEKEEVTQVEEKAVE	RYR3	1766	Q15413
EEQENETVVVKEKMV	TLN1	2481	Q9Y490
KDSVDTVAIKVEEDE	TMIE	131	Q8NEW7
IEEEKVEKIELNDSV	RELL1	96	Q8IUW5
ILEEEEEEEQKIGKV	XPA	76	P23025
EIKVEVEVEVKEEEN	ZFP91	261	Q96JP5
DTEVEETQEEKIKLE	ZC3H8	31	Q8N5P1
AEEAKKEQVEEDNEV	GOLGB1	941	Q14789
EIVKTISVKVIDDEE	SLC8A1	601	P32418
QIEVEETIEAAKAEE	NEFL	451	P07196